← Oncology Approval Tracker

FDA DECISION ·

Opdivo

nivolumab · Bristol Myers Squibb

Traditional approvalTraditional conversionClassical Hodgkin lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with relapsed or refractory classical Hodgkin lymphoma after at least three lines of systemic therapy that include autologous stem-cell transplant.

LAMPGEN ANALYSIS

Why it matters

This converts a later-line accelerated indication. Count prior therapy lines and note transplant history when describing who falls within the approved population.

What research teams should watch

Review how each prior line and the autologous transplant were documented. Keep later-line evidence distinct from the randomized first-line combination study.

PRIMARY RECORDS

Sources